Cargando…

The New Radiolabeled Peptide (99m)TcEDDA/HYNIC-TOC: Is It a Feasible Choice for Diagnosing Gastroenteropancreatic NETs?

SIMPLE SUMMARY: Gastroenteropancreatic neuroendocrine tumors are a group of heterogenous tumors that account for about 60% of the neuroendocrine tumors diagnosed nowadays. They possess the capability to synthesize and secrete peptides and hormones that lead to their characteristic syndromes. One of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gherghe, Mirela, Lazăr, Alexandra Maria, Stanciu, Adina Elena, Mutuleanu, Mario-Demian, Sterea, Maria-Carla, Petroiu, Cristina, Galeș, Laurenția Nicoleta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179571/ https://www.ncbi.nlm.nih.gov/pubmed/35681704 http://dx.doi.org/10.3390/cancers14112725

Ejemplares similares

(99m)Tc-EDDA/HYNIC-TOC is a New Opportunity in Neuroendocrine Tumors of the Lung (and in other Malignant and Benign Pulmonary Diseases)
por: Briganti, Vittorio, et al.
Publicado: (2020)

Quantitative SPECT/CT Parameters in the Assessment of Transthyretin Cardiac Amyloidosis—A New Dimension of Molecular Imaging
por: Gherghe, Mirela, et al.
Publicado: (2023)

Clinical validation and diagnostic accuracy of (99m)Tc-EDDA/HYNIC-TOC compared to (111)In-DTPA-octreotide in patients with neuroendocrine tumours: the LACOG 0214 study
por: Moriguchi-Jeckel, Cristina M, et al.
Publicado: (2023)

(99m)Tc-Hynic-TOC imaging in the diagnostic of neuroendocrine tumors
por: Liepe, Knut, et al.
Publicado: (2018)

Evaluating Cardiotoxicity in Breast Cancer Patients Treated with HER2 Inhibitors: Could a Combination of Radionuclide Ventriculography and Cardiac Biomarkers Predict the Cardiac Impact?
por: Gherghe, Mirela, et al.
Publicado: (2022)

(99m)Tc-HYNIC-(tricine/EDDA)-FROP peptide for MCF-7 breast tumor targeting and imaging
por: Ahmadpour, Sajjad, et al.
Publicado: (2018)

Radiomics Analysis of [(18)F]FDG PET/CT Thyroid Incidentalomas: How Can It Improve Patients’ Clinical Management? A Systematic Review from the Literature
por: Gherghe, Mirela, et al.
Publicado: (2022)

The Diagnostic Efficiency of 99mTc-EDDA/HYNIC-Octreotate SPECT-CT in Comparison with 111In-Pentetrotide in the Detection of Neuroendocrine Tumours
por: Koçyiğit Deveci, Emel, et al.
Publicado: (2013)

Evaluation of [(99m)Tc][Tc-HYNIC/EDDA]-Tyr as a target for metabolic tumor imaging in B16F10 melanoma tumor
por: Yaghoubi Mogadam, Hemat, et al.
Publicado: (2022)

Standardized Uptake Values on SPECT/CT: A Promising Alternative Tool for Treatment Evaluation and Prognosis of Metastatic Neuroendocrine Tumours
por: Gherghe, Mirela, et al.
Publicado: (2023)

Value of Somatostatin Receptor Scintigraphy with (99m)Tc-HYNIC-TOC in Patients with Primary Sjögren Syndrome
por: Anzola, Luz Kelly, et al.
Publicado: (2019)

Diagnostic accuracy of (99m)Tc-HYNIC-TOC SPECT/CT for detecting osteomalacia-associated tumors
por: Li, Bo, et al.
Publicado: (2023)

Quantitative vs. Qualitative SPECT-CT Diagnostic Accuracy in Bone Lesion Evaluation—A Review of the Literature
por: Mutuleanu, Mario-Demian, et al.
Publicado: (2023)

Quantitative Analysis of SPECT-CT Data in Metastatic Breast Cancer Patients—The Clinical Significance
por: Gherghe, Mirela, et al.
Publicado: (2022)

Clinical usefulness of (99m)Tc-HYNIC-TOC, (99m)Tc(V)-DMSA, and (99m)Tc-MIBI SPECT in the evaluation of pituitary adenomas
por: Vukomanovic, Vladimir R., et al.
Publicado: (2019)

Multiple Cutaneous Metastases on (99m)TC-HYNIC-TOC Scan in a Rare Case of Malignant Laryngeal Paraganglioma
por: Sankar, Gowri, et al.
Publicado: (2018)

Glucagon-like peptide-1 receptor imaging with [Lys(40)(Ahx-HYNIC-(99m)Tc/EDDA)NH(2)]-exendin-4 for the detection of insulinoma
por: Sowa-Staszczak, Anna, et al.
Publicado: (2012)

Quantitative Assessment of Treatment Response in Metastatic Breast Cancer Patients by SPECT-CT Bone Imaging—Getting Closer to PET-CT
por: Gherghe, Mirela, et al.
Publicado: (2023)

Somatostatin Receptor SPECT/CT using (99m)Tc Labeled HYNIC-TOC Aids in Diagnosis of Primary Optic Nerve Sheath Meningioma
por: Chandra, Piyush, et al.
Publicado: (2017)

Site-based performance of (131)I-MIBG imaging and (99m)Tc-HYNIC-TOC scintigraphy in the detection of nonmetastatic extra-adrenal paraganglioma
por: Hou, Guozhu, et al.
Publicado: (2021)

Predictive Value of 99MTC-hynic-toc Scintigraphy in Lung Neuroendocrine Tumor Diagnosis
por: Boutsikou, Efimia, et al.
Publicado: (2019)

Understanding COVID Vaccination and Its Implication in Cancer Patients’ Imaging of Lymph Nodes by PET-CT
por: Gales, Laurentia Nicoleta, et al.
Publicado: (2022)

Utility of (99m)Tc-Hynic-TOC in 131I Whole-Body Scan Negative Thyroid Cancer Patients with Elevated Serum Thyroglobulin Levels
por: Shinto, Ajit S., et al.
Publicado: (2015)

Edda menor
Publicado: (1984)

Edda Mayor
Publicado: (1986)

Glucagon-Like Peptide-1 Receptor Imaging with [Lys(40)(Ahx-HYNIC-(99m)Tc/EDDA)NH(2)]-Exendin-4 for the Diagnosis of Recurrence or Dissemination of Medullary Thyroid Cancer: A Preliminary Report
por: Pach, D., et al.
Publicado: (2013)

Synthesis, Radiolabeling, and Biological Evaluation of Peptide LIKKPF Functionalized with HYNIC as Apoptosis Imaging Agent
por: Khoshbakht, Sepideh, et al.
Publicado: (2016)

HYNIC and DOMA conjugated radiolabeled bombesin analogs as receptor-targeted probes for scintigraphic detection of breast tumor
por: De, Kakali, et al.
Publicado: (2019)

Clinical utility of indigenously formulated single-vial lyophilized HYNIC-TOC kit in evaluating Gastro-entero Pancreatic neuro endocrine tumours
por: Shinto, Ajit S, et al.
Publicado: (2014)

Incidental Synchronous (99m)Tc-HYNIC-TOC Avid Lesion of the Neck in a Patient with Metastatic Melanoma: A Metastatic Lymph Node or a Carotid Body Tumor Masquerading As a Lymph Node?
por: Roshanravan, Vahid, et al.
Publicado: (2022)

Feasibility of Sentinel Lymph Node Biopsy in Breast Cancer Patients with Axillary Conversion after Neoadjuvant Chemotherapy—A Single-Tertiary Centre Experience and Review of the Literature
por: Lazar, Alexandra Maria, et al.
Publicado: (2023)

Patient-specific dosimetry of (99m)Tc-HYNIC-Tyr(3)-Octreotide in children
por: Hou, Xinchi, et al.
Publicado: (2017)

Evaluation of Radiation dosimetry of (99m)Tc-HYNIC-PSMA and imaging in prostate cancer
por: Zhang, Jianping, et al.
Publicado: (2020)

A novel molecular imaging probe [(99m)Tc]Tc-HYNIC-FAPI targeting cancer-associated fibroblasts
por: Jiang, Yanghongyan, et al.
Publicado: (2023)

Cholecystokinin-2 Receptor Targeting with Novel C-terminally Stabilized HYNIC-Minigastrin Analogs Radiolabeled with Technetium-99m
por: Klingler, Maximilian, et al.
Publicado: (2019)

Analysis of Efficacy-To-Safety Ratio of Angiogenesis-Inhibitors Based Therapies in Ovarian Cancer: A Systematic Review and Meta-Analysis
por: Simion, Laurentiu, et al.
Publicado: (2023)

(99m)Tc-Labeled HYNIC-DAPI Causes Plasmid DNA Damage with High Efficiency
por: Kotzerke, Joerg, et al.
Publicado: (2014)

EDDA: An Efficient Distributed Data Replication Algorithm in VANETs
por: Zhu, Junyu, et al.
Publicado: (2018)

(99m)Tc-HYNIC-Annexin A5 in Oncology: Evaluating Efficacy of Anti-Cancer Therapies
por: Schaper, Frédéric L.W.V.J., et al.
Publicado: (2013)

Author Correction: Evaluation of Radiation dosimetry of (99m)Tc-HYNIC-PSMA and imaging in prostate cancer
por: Zhang, Jianping, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9gmddb9q73jtipp1t6n6oa9p9e